Trials / Completed
CompletedNCT00318851
Carotid Artery Stenting With Protection Registry
Treatment of Carotid Stenosis With Carotid Stenting and Neurologic Protection With Pre-Procedure and Follow-Up With MRI DIffusion Imaging and Neuropsychological Testing
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- Providence Health & Services · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate ischemic events and neuropsychological changes after carotid artery angioplasty and stenting with a neuroprotection device.
Detailed description
Stroke is the third most common cause of death in North America with approximately 750,000 new strokes reported annually, of which 150,000 are fatal. Approximately 75% of strokes occur in the distribution of the carotid arteries. Among those, a thrombotic etiology (carotid occlusive disease) is one of the most common causes. Recently published studies have shown that patients who underwent carotid stenting in combination with a cerebral protection device had better overall outcomes as related to stroke, death and MI as opposed to carotid endarterectomy. What is not known is whether protection devices which allow some particles (100 micron particle size or less) to pass through the filter or particles that embolize during placement or removal of the protection device, will have any delayed abnormal outcomes as determined by neuropsychological testing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Carotid Stent with Distal Protection Device | Carotid Stent Placement with Distal Protection |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2007-08-01
- Completion
- 2007-08-01
- First posted
- 2006-04-27
- Last updated
- 2010-08-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00318851. Inclusion in this directory is not an endorsement.